These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


286 related items for PubMed ID: 16638693

  • 1. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population.
    Lopes AI, Palha A, Lopes T, Monteiro L, Oleastro M, Fernandes A.
    Scand J Gastroenterol; 2006 May; 41(5):524-31. PubMed ID: 16638693
    [Abstract] [Full Text] [Related]

  • 2. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M.
    Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
    [Abstract] [Full Text] [Related]

  • 4. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, Ishii H, Hibi T.
    Hepatogastroenterology; 2004 Jul; 51(59):1249-54. PubMed ID: 15362725
    [Abstract] [Full Text] [Related]

  • 5. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N.
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [Abstract] [Full Text] [Related]

  • 6. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
    Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, Rafiee R, Shahidi SM, Nikbin B, Khosravi F, Massarrat S.
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
    [Abstract] [Full Text] [Related]

  • 7. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
    Gisbert JP, Boixeda D, Al-Mostafa A, Vila T, de Rafael L, Alvarez Baleriola I, de Argila CM, Abraira V.
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
    [Abstract] [Full Text] [Related]

  • 8. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q, Ran ZH, Xiao SD.
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [Abstract] [Full Text] [Related]

  • 9. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
    Germaná B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, Comparato G, Carloni C, Bertiato G, Battiestel M, Papa N, Aragona G, Cavestro GM, Iori V, Merli R, Bertolini S, Caruana P, Franzé A.
    Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
    [Abstract] [Full Text] [Related]

  • 10. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K.
    J Gastroenterol; 2003 Jul; 38(4):332-8. PubMed ID: 12743772
    [Abstract] [Full Text] [Related]

  • 11. Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa.
    Chuang CH, Sheu BS, Yang HB, Kao AW, Cheng HC, Yao WJ.
    J Gastroenterol Hepatol; 2004 Sep; 19(9):988-93. PubMed ID: 15304114
    [Abstract] [Full Text] [Related]

  • 12. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X, Lu B, Meng L, Fan Y, Zhang S, Li M.
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [Abstract] [Full Text] [Related]

  • 13. Changes in the histology and function of gastric mucosa and in Helicobacter pylori colonization during a long-term follow-up period after vagotomy in duodenal ulcer patients.
    Peetsalu M, Valle J, Härkönen M, Maaroos HI, Peetsalu A.
    Hepatogastroenterology; 2005 Aug; 52(63):785-91. PubMed ID: 15966205
    [Abstract] [Full Text] [Related]

  • 14. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT, Miki K, Walsh JH, Graham DP, Asaka M, Graham DY.
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [Abstract] [Full Text] [Related]

  • 15. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L, Storskrubb T, Aro P, Ronkainen J, Talley NJ, Sipponen P.
    Scand J Gastroenterol; 2009 Sep; 44(5):564-70. PubMed ID: 19263272
    [Abstract] [Full Text] [Related]

  • 16. [Pepsinogen and gastrin in the noninvasive diagnosis of gastric atrophy. A case-control study in Peruvian population].
    Colarossi A, Inga R, Prochazka R, Reyes U, Bussalleu A, Barúa RL.
    Rev Gastroenterol Peru; 2011 Sep; 31(2):110-5. PubMed ID: 21836650
    [Abstract] [Full Text] [Related]

  • 17. Effect of Helicobacter pylori infection on gastric acid secretion and meal-stimulated serum gastrin in children.
    Kato S, Ozawa K, Koike T, Sekine H, Ohara S, Minoura T, Iinuma K.
    Helicobacter; 2004 Apr; 9(2):100-5. PubMed ID: 15068410
    [Abstract] [Full Text] [Related]

  • 18. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI, de Aretxabala U X, Santander D R, Sabah T S, Maira S J, Navarro R A, Planzer D M, Gómez L F, Etchart M, Gallegos I, Torrens X, Fasce P G, Reydet I.
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [Abstract] [Full Text] [Related]

  • 19. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C, Bölükbaş FF, Ovünç O, Kiliç G, Dalay R, Güven H, Uras F, Yardimci TK, Sökmen MH, Agan AF, Pişkinpaşa N.
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [Abstract] [Full Text] [Related]

  • 20. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
    Ricci C, Vakil N, Rugge M, Gatta L, Perna F, Osborn JF, Russo VM, Tampieri A, Bernabucci V, Miglioli M, Vaira D.
    Am J Gastroenterol; 2004 Oct; 99(10):1910-5. PubMed ID: 15447749
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.